Supplementary Table 2.
Balanced test of baseline data after matching.
| No response to GC (n=27) | Response to GC (n=9) | Standardized difference absolute value | P-value | |
|---|---|---|---|---|
| Age (year, mean ±SD) | 36.89±20.97 | 39.11±23.19 | 0.1005 | 0.79 |
| Height (cm, mean ±SD) | 163.74±7.13 | 163.11±7.25 | 0.0875 | 0.8207 |
| Weight (kg, mean ±SD) | 59.48±9.22 | 60.44±11.48 | 0.0925 | 0.8 |
| Sex (n, %) | 0 | 1 | ||
| Male | 9 (33.3) | 3 (33.3) | ||
| Female | 18 (66.7) | 6 (66.7) | ||
| Smoking (n, %) | 0.6412 | |||
| No | 21 (77.8) | 7 (77.8) | 0 | |
| Current smoker | 5 (18.5) | 1 (11.1) | 0.2097 | |
| Ex-smoker | 1 (3.7) | 1 (11.1) | 0.2857 | |
| Alcohol consumption (n, %) | 0.1104 | 1 | ||
| No | 23 (85.2) | 8 (88.9) | ||
| Yes | 4 (14.8) | 1 (11.1) | ||
| HP infection (n, %) | 0.0743 | 1 | ||
| Negative | 14 (51.9) | 5 (55.6) | ||
| Positive | 13 (48.1) | 4 (44.4) | ||
| Hyperuricemia (n, %) | 0.4 | 1 | ||
| No | 25 (92.6) | 9 (100) | ||
| Yes | 2 (7.4) | 0 (0) | ||
| Diabetes history (n, %) | 0.1104 | 1 | ||
| No | 23 (85.2) | 8 (88.9) | ||
| Yes | 4 (14.8) | 1 (11.1) | ||
| Cardiovascular diseases (n, %) | 0.4 | 1 | ||
| No | 25 (92.6) | 9 (100) | ||
| Yes | 2 (7.4) | 0 (0) | ||
| Bleeding in skin (n, %) | 0.0743 | 1 | ||
| No | 14 (51.9) | 5 (55.6) | ||
| Yes | 13 (48.1) | 4 (44.4) | ||
| Bleeding in mucosa (n, %) | 0.075 | 1 | ||
| No | 16 (59.3) | 5 (55.6) | ||
| Yes | 11 (40.7) | 4 (44.4) | ||
| Bleeding in organ (n, %) | 0.128 | 1 | ||
| No | 25 (92.6) | 8 (88.9) | ||
| Yes | 2 (7.4) | 1 (11.1) | ||
| High-dose dexamethasone (n, %) | 0.0776 | 1 | ||
| No | 17 (63) | 6 (66.7) | ||
| Yes | 10 (37) | 3 (33.3) | ||
| Oral prednisone (n, %) | 0.0776 | 1 | ||
| No | 10 (37) | 3 (33.3) | ||
| Yes | 17 (63) | 6 (66.7) |
GC – glucocorticoid; PLR – platelet to lymphocyte ratio; SD – standard deviation; HP – Helicobacter pylori.